About WaferGen
WaferGen is a company based in Fremont (United States) founded in 2002 was acquired by Takara Bio in May 2016.. WaferGen offers products and services including Biotech Kits, Reagents, and Instruments. WaferGen operates in a competitive market with competitors including Arbor Biotechnologies, Singleron, Octant, Diagenode and Factor Bioscience, among others.
- Headquarter Fremont, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Takara Bio Usa, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$510 K (USD), Post-IPO
Aug 22, 2014
-
Investors
Takara Bio
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Takara Bio
(May 13, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of WaferGen
WaferGen offers a comprehensive portfolio of products and services, including Biotech Kits, Reagents, and Instruments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kits for gene discovery and nucleic acid purification
Reagents for PCR and gene editing processes
Instruments for single-cell sequencing and analysis
Funding Insights of WaferGen
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $510,000
-
First Round
First Round
(31 May 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2014 | Amount | Post-IPO - WaferGen | Valuation |
investors |
|
| Sep, 2013 | Amount | Post-IPO - WaferGen | Valuation |
investors |
|
| Sep, 2013 | Amount | Post-IPO - WaferGen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in WaferGen
WaferGen has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Takara Bio, Oxford Finance and Great Point Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on company buyouts
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by WaferGen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - WaferGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wafergen Comparisons
Competitors of WaferGen
WaferGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arbor Biotechnologies, Singleron, Octant, Diagenode and Factor Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for epigenetics sequencing solutions are developed.
|
|
| domain | founded_year | HQ Location |
Genomic technologies are developed to treat diseases and enhance health.
|
|
| domain | founded_year | HQ Location |
Creates innovative in-vitro diagnostic technologies for cancer detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about WaferGen
When was WaferGen founded?
WaferGen was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is WaferGen located?
WaferGen is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
What does WaferGen do?
WaferGen offers a set of tools for molecular and single-cell analysis in the life sciences, pharmaceutical, and clinical laboratory industries. Its products include ICELL8 Single-Cell System (for single-cell research); NGS Library Prep system, SmartChip NGS Target Enrichment System and Real-Time PCR System. It also provides chips, printed panels, primers and reagent kits for Single Cell Analysis, NGS Sample Prep, and Clinical Research.
Who are the top competitors of WaferGen?
WaferGen's top competitors include Arbor Biotechnologies, Singleron and Diagenode.
What products or services does WaferGen offer?
WaferGen offers Biotech Kits, Reagents, and Instruments.
Who are WaferGen's investors?
WaferGen has 5 investors. Key investors include Takara Bio, Oxford Finance, Great Point Partners, Deerfield, and Merlin Nexus.